Pulmonx (LUNG) Cash from Investing Activities Growth (3y) (2022 - 2025)
Pulmonx (LUNG) Cash from Investing Activities Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -17.67% |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 482.83% |
| Jun 30, 2025 | 38.04% |
| Mar 31, 2025 | 69.87% |
| Dec 31, 2024 | 35.41% |
| Sep 30, 2024 | 58.44% |
| Jun 30, 2024 | 11.04% |
| Mar 31, 2024 | 41.51% |
| Dec 31, 2023 | -58.41% |
| Sep 30, 2023 | 146.55% |
| Jun 30, 2023 | -30.77% |
| Mar 31, 2023 | -61.46% |
| Dec 31, 2022 | -30.85% |